ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

Veeva Systems and Zifo have partnered to help biopharmas modernize quality control (QC) operations by bringing together Veeva ...

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...

As Bora Biologics, the organization will continue to build upon its established reputation for quality and excellence in ...

The goal is to treat familial dysautonomia patients with a single injection.

Coeptis Therapeutics Holdings Inc., a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

The approval was based on results from the TROPION-Breast01 Phase III trial.

Kyverna Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Naji Gehchan, M.D., MBA, as Chief ...

Medix Biochemica, a supplier of critical raw materials for the in vitro diagnostics (IVD) industry, has acquired Candor ...